Product Name :
AZD1283
Description:
AZD1283 is a potent antagonist of the P2Y12 receptor. In a modified Folts model in dog, both AZD1283 dose-dependently induced increases in blood flow and inhibition of ADP-induced platelet aggregation with antithrombotic ED50 values of 3.0 μg/kg/min. The doses that induced a larger than 3-fold increase in bleeding time were 33 μg/kg/min. Thus, the therapeutic index (TI) was ≥ 10. On the basis of these data, AZD1283 was progressed into human clinical trials as candidate drug.
CAS:
919351-41-0
Molecular Weight:
470.54
Formula:
C23H26N4O5S
Chemical Name:
ethyl 5-cyano-2-methyl-6-[4-(phenylmethanesulfonylcarbamoyl)piperidin-1-yl]pyridine-3-carboxylate
Smiles :
CC1=NC(=C(C=C1C(=O)OCC)C#N)N1CCC(CC1)C(=O)NS(=O)(=O)CC1C=CC=CC=1
InChiKey:
NEMHKCNXXRQYRF-UHFFFAOYSA-N
InChi :
InChI=1S/C23H26N4O5S/c1-3-32-23(29)20-13-19(14-24)21(25-16(20)2)27-11-9-18(10-12-27)22(28)26-33(30,31)15-17-7-5-4-6-8-17/h4-8,13,18H,3,9-12,15H2,1-2H3,(H,26,28)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
AZD1283 is a potent antagonist of the P2Y12 receptor. In a modified Folts model in dog, both AZD1283 dose-dependently induced increases in blood flow and inhibition of ADP-induced platelet aggregation with antithrombotic ED50 values of 3.0 μg/kg/min. The doses that induced a larger than 3-fold increase in bleeding time were 33 μg/kg/min.{{Fmoc-Thr(tBu)-OH} MedChemExpress|{Fmoc-Thr(tBu)-OH} {Amino Acid Derivatives}|{Fmoc-Thr(tBu)-OH} TGF-beta/Smad|{Fmoc-Thr(tBu)-OH} Protocol|{Fmoc-Thr(tBu)-OH} Formula|{Fmoc-Thr(tBu)-OH} custom synthesis} Thus, the therapeutic index (TI) was ≥ 10. On the basis of these data, AZD1283 was progressed into human clinical trials as candidate drug.|Product information|CAS Number: 919351-41-0|Molecular Weight: 470.{{Moxifloxacin} medchemexpress|{Moxifloxacin} Anti-infection|{Moxifloxacin} Biological Activity|{Moxifloxacin} In Vitro|{Moxifloxacin} custom synthesis|{Moxifloxacin} Epigenetics} 54|Formula: C23H26N4O5S|Chemical Name: ethyl 5-cyano-2-methyl-6-[4-(phenylmethanesulfonylcarbamoyl)piperidin-1-yl]pyridine-3-carboxylate|Smiles: CC1=NC(=C(C=C1C(=O)OCC)C#N)N1CCC(CC1)C(=O)NS(=O)(=O)CC1C=CC=CC=1|InChiKey: NEMHKCNXXRQYRF-UHFFFAOYSA-N|InChi: InChI=1S/C23H26N4O5S/c1-3-32-23(29)20-13-19(14-24)21(25-16(20)2)27-11-9-18(10-12-27)22(28)26-33(30,31)15-17-7-5-4-6-8-17/h4-8,13,18H,3,9-12,15H2,1-2H3,(H,26,28)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.PMID:25023702 |Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|